<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101190261</journal-id>
<journal-id journal-id-type="pubmed-jr-id">31733</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Rev Microbiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Rev. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Microbiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1740-1526</issn>
<issn pub-type="epub">1740-1534</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31249397</article-id>
<article-id pub-id-type="pmc">6759048</article-id>
<article-id pub-id-type="doi">10.1038/s41579-019-0213-6</article-id>
<article-id pub-id-type="manuscript">NIHMS1050393</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microbial genes and pathways in inflammatory bowel disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Schirmer</surname>
<given-names>Melanie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garner</surname>
<given-names>Ashley</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vlamakis</surname>
<given-names>Hera</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="corresp" rid="CR2">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xavier</surname>
<given-names>Ramnik J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR3">***</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Broad Institute of MIT and Harvard, Cambridge, MA, USA</aff>
<aff id="A2"><label>2</label>Center for Microbiome Informatics and Therapeutics, MIT, Cambridge, MA, USA</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author contributions</p>
<p id="P2">M.S., A.G., H.V., and R.J.X. conceived and wrote the article. All authors substantially contributed to discussion of content and reviewed/edited the manuscript before submission. M.S. generated <xref ref-type="fig" rid="F2">Figure 2</xref>.</p>
</fn>
<corresp id="CR1">
<label>*</label>
<email>melanie@broadinstitute.org</email>
</corresp>
<corresp id="CR2">
<label>**</label>
<email>hera@broadinstitute.org</email>
</corresp>
<corresp id="CR3">
<label>***</label>
<email>xavier@molbio.mgh.harvard.edu</email>
</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P46">Competing interests</p>
<p id="P47">The authors declare no competing interests.</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p id="P48">Supplementary information</p>
<p id="P49"><xref ref-type="supplementary-material" rid="SD1">Supplementary information</xref> is available for this paper at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41579-019-0213-6">https://doi.org/10.1038/s41579-019-0213-6</ext-link>.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2020</year>
</pub-date>
<volume>17</volume>
<issue>8</issue>
<fpage>497</fpage>
<lpage>511</lpage>
<!--elocation-id from pubmed: 10.1038/s41579-019-0213-6-->
<abstract id="ABS1">
<p id="P3">Perturbations in the intestinal microbiome are implicated in inflammatory bowel disease (IBD). Studies of treatment-naive patients have identified microbial taxa associated with disease course and treatment efficacy. In order to gain a mechanistic understanding of how the microbiome impacts gastrointestinal health, we need to move from census to function. Bacteria including those that adhere to epithelial cells as well as several <italic>Clostridium</italic> species can alter differentiation of T helper 17 cells and regulatory T cells. Similarly, microbial products such as short-chain fatty acids and sphingolipids also influence immune responses. Metagenomics and culturomics have identified strains of <italic>Ruminococcus gnavus</italic> and adherent invasive <italic>Escherichia coli</italic> that are linked to IBD and gut inflammation. Integrated analysis of multi-omics data, including metagenomics, metatranscriptomics, and metabolomics, with measurements of host response and culturomics have great potential in understanding the role of the microbiome in IBD. In this Review, we highlight current knowledge of gut microbial factors linked to IBD pathogenesis and discuss how multi-omics data from large-scale population studies in health and disease have been used to identify specific microbial strains, transcriptional changes, and metabolic alterations associated with IBD.</p>
</abstract>
<abstract abstract-type="summary" id="ABS2">
<title>Table of contents blurb</title>
<p id="P4">Perturbations in the intestinal microbiome are implicated in inflammatory bowel disease (IBD). In this Review, Xavier and colleagues highlight current knowledge of gut microbial factors linked to IBD pathogenesis and discuss how multi-omics data from large-scale population studies in health and disease have been used to identify specific microbial strains, transcriptional changes and metabolic alterations associated with IBD.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>